BioAge Labs (BIOA) Assets Average (2024 - 2026)

BioAge Labs (BIOA) has 3 years of Assets Average data on file, last reported at $346.3 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 1.36% year-over-year to $346.3 million; the trailing twelve-month figure through Mar 2026 stood at $346.3 million (down 1.36% YoY), and the FY2025 full-year result was $326.6 million, up 70.01% from the prior year.
• Assets Average climbed to $346.3 million in Q1 2026, from $300.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $351.0 million in Q1 2025 to a low of $300.0 million in Q4 2025.
• A 3-year average of $332.0 million and a median of $339.6 million in 2025 frame the typical range for Assets Average.
• Across the five-year window, Assets Average retreated 13.75% in 2025 and declined 1.36% in 2026, its largest moves.
• Tracing BIOA's Assets Average over 3 years: stood at $347.8 million in 2024, then retreated by 13.75% to $300.0 million in 2025, then advanced by 15.43% to $346.3 million in 2026.
• Business Quant data shows BIOA's Assets Average at $346.3 million in Q1 2026, $300.0 million in Q4 2025, and $313.6 million in Q3 2025.